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Abstract. In the last three decades, high rates of resistance to common first-line antimicrobial agents have been
reported in Salmonella enterica serotype Typhi (Typhi), the causative organism of typhoid fever (TF), in many regions
of the world, especially in South East Asia. Analysis of Typhi strains isolated from outbreaks and sporadic cases of TF
in Son La province, northwest Vietnam, in 2002 revealed that 94.5% (85/90) of the isolates were fully susceptible to
amoxicillin, chloramphenicol, cotrimoxazole, tetracycline, and nalidixic acid. There was a clear decline in the occurrence
of multi-drug resistant (MDR) Typhi isolates collected in this province in 2002 (4.4%) compared with the period
1995–1999 in the same province (30.8–100%). By using molecular (IS200 profiling, PstI-ribotyping, XbaI-pulsed-field gel
electrophoresis, and haplotyping) and phage-typing methods, we showed that the Typhi isolates from Son La province
in 2002 were genetically related; however, they were unrelated to the previous MDR clones established in Vietnam.
INTRODUCTION
Typhoid fever (TF) remains a major health problem in the
world, with an estimate of > 20 million cases resulting in
> 200,000 deaths during 2000, mostly in developing coun-
tries.
1 Treatment with appropriate antibiotics is essential for
recovery. However, treatment has become progressively
more problematic with the gradual emergence of antimicro-
bial resistance.
2 In the last three decades, high rates of resis-
tance to common first-line antimicrobial agents have been
reported in Salmonella enterica serotype Typhi (hereafter re-
ferred to as Typhi) in many regions of the world.
2 Multiple
resistance to ampicillin, chloramphenicol, cotrimoxazole, and
tetracycline (ACSxtTe resistance type) is encoded by large
conjugative plasmids mostly belonging to the incompatibility
complex group IncHI.
3–6 The Indian subcontinent and South-
east Asian countries are particularly affected by multidrug
resistant (MDR) Typhi strains.
2,7–9 In Vietnam, the spread of
MDR Typhi (ACSxtTe R-type) was first reported in 1992–
1993 in the southern part of the country.
10 In 1994, > 80% of
Typhi isolates were MDR in southern Vietnam, but only 5%
and 10% of MDRST strains were isolated in the center and
the north, respectively.
8 During the period 1995–2002, a study
found that > 90% of sporadic and epidemic Typhi strains
from the center and the north were MDR.
8 The economic
reforms in Vietnam in the early 1990s had resulted in a boom
in private pharmacies and all first line antibiotics for TF could
be bought as over-the-counter medicines without prescrip-
tions, leading to misuse and abuse of these drugs.
11 Because
of the widespread occurrence of MDR Typhi strains, quino-
lones and fluoroquinolones, in particular, were used in the
first-line treatment of adults in several countries, including
Vietnam. However, the emergence of MDR Typhi isolates
with an additional chromosomally encoded resistance to na-
lidixic acid (MDR-Nal
R) and with reduced susceptibility to
ciprofloxacin has been increasingly reported since the begin-
ning of the 1990s on the Indian subcontinent and afterwards
in different Asian countries.
12–17 Several reports indicated
that MDR-Nal
R Typhi strains were associated with slower
clinical responses to fluoroquinolones or treatment fail-
ures.
12,18,19 In Vietnam, MDR-Nal
R Typhi isolates were first
reported in 1993 and increased dramatically in 1997 in the
south of the country.
12,20 As outbreaks of TF are reported
every year in various parts of Vietnam, the emergence of
MDR-Nal
R Typhi isolates is of great concern because TF
caused by such isolates would require treatment with expen-
sive, third-generation cephalosporins that are unaffordable
for most people in Vietnam. Furthermore, the average cost of
admission to Vietnamese hospitals (including bed fees, health
care professionals, and cost of treatment) for a patient in-
fected with MDR-Nal
R Typhi has been estimated to be USD
50 compared with USD 22 for a patient infected with a sus-
ceptible strain.
21
In northern Vietnam, MDR Typhi strains were reported in
most provinces: Lao Cai, Lai Chau, Thanh Hoa, and Son La,
since the mid-1990s (H. Tran, unpublished results). From July
to December 2002, a hospital-based study aiming at identify-
ing risk factors associated with TF in Son La province was
conducted by some of us (H.H.T., B.M.N., G.B., and
P.J.G.).
22 During the study period, three probable outbreaks
were detected in three geographically distinct districts: Quynh
Nhai district (23 cases, attack rate: 1.6%), in Phu Yen district
(32 cases, attack rate: 2.9%), and in Thuan Chau district (28
cases, attack rate: 2.9%). Three risk factors were statistically
associated with TF: no education (odds ratio [OR]  2.0,
95% confidence interval [CI] 1.0–3.7), contact with typhoid
case (OR  3.3, 95% CI 1.7–6.2), and drinking untreated
water from streams or wells (OR  3.9, 95% CI 2.0–7.5).
22 As
only five cases had a history of travel to Son La, the provincial
town, the sources of infection were attributed to carriers from
each community. We present here a microbiological com-
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1174parative study (antibiotyping, molecular, and phage typing) of
S. enterica serotype Typhi isolates collected during the previ-
ous study to explore how this could help to understand the
mode of acquisition of TF in Son La province in 2002.
MATERIALS AND METHODS
Study place. The research was conducted in Son La prov-
ince, in northwest Vietnam, 320 km from the capital Hanoi.
This province, 80% covered by mountains, is difficult to ac-
cess. Son La town is the main town of this province, subdi-
vided into nine districts. The standard of living of the popu-
lation is very low, and income per capita is among the poorest
compared with other provinces in Vietnam (USD 130/person/
year).
23 TF is of great concern in Son La province with out-
breaks reported in several districts from 1998 to 2001.
Patients and sampling. The patients in this study were re-
cruited for a confirmed TF in provincial and district hospitals
of Son La province between 1 July and 30 December 2002, as
reported previously.
22 One blood and one stool sample were
obtained for each patient. Diagnosis of TF was made by iso-
lation of Typhi from blood and/or from stool associated with
clinical symptoms compatible with recent TF infection, i.e.
fever over 38°C for more than 3 days with no other evident
diagnosis to explain this fever.
Origin and identification of Typhi isolates. Blood samples
(5 mL for patients older than 5 years old, and at least 2 mL for
children under 5 years old) were inoculated into Brain Heart
Infusion broth (Difco, Detroit, MI) and incubated at 35–37°C
for 10 days. Vials were checked for growth twice daily on the
first 2 days, once on day 3 and day 4, and once on day 10.
Positive vials were subcultured on blood, MacConkey, and
Salmonella–Shigella agar plates (SS agar, Difco). A stool
sample was collected at the same time as the blood sample.
Stool (3 g) was inoculated into selenite broth enrichment me-
dium (Difco), incubated at 35–37°C for 18–24 hours and then
subcultured on MacConkey and SS agar. Identification of
Typhi was performed in Son La Health Center Microbiology
Department using biochemical tests and agglutination with O,
H, and Vi antisera (Difco). Suspected Typhi strains were sent
for confirmation to the National Reference Laboratory of
Enteric Pathogens, National Institute of Hygiene and Epide-
miology (NIHE), Hanoi, Vietnam. Molecular and phage-
typing studies were carried out at the French National Ref-
erence Center for Salmonella (NRC-Salm), Institut Pasteur,
Paris, France. Typhi strains 162/95, 230/95, 14/96, 119/96, 339/
98, 358/98, and CM2664 collected in Vietnam from 1995 to
2002 and used as comparison strains (CS) were from the
NRC-Salm collection. Typhi reference strain Ty-2 was from
the WHO Collaborating Center for Reference and Research
on Salmonella, Institut Pasteur, Paris, France.
Antimicrobial susceptibility testing. Antimicrobial suscep-
tibility testing was performed on Typhi isolates from Son-La,
2002 using the Paper Disc Method (PDM-Biodisk, Stock-
holm, Sweden) at the National Reference Laboratory for En-
teropathogenic Bacteria, Norwegian Institute of Public
Health, Oslo, Norway, using Clinical and Laboratory Stan-
dards Institute (CLSI, formerly National Committee for
Clinical Laboratory Standards) guidelines.
24,25 The following
disks were used: amoxicillin (10 g), amoxicillin + clavulanic
acid (20 g+1 0g), streptomycin (30 g), tetracycline (30
g), ceftriaxone (30 g), azithromycin (15 g), chloramphen-
icol (30 g), sulfamethoxazole (23,8 g), trimethoprim (5 g),
nalidixic acid (30 g), norfloxacin (10 g), and ciprofloxacin
(10 g). Escherichia coli ATCC 25922 was used as a control.
To assess temporal changes that may have occurred in the
resistance profile of Typhi in Son La province, we also
present the results of antimicrobial susceptibility testing of
116 Typhi strains collected during outbreaks or routine sur-
veillance in this province between 1995 and 1999. Isolates
were sent to NIHE for confirmation and antibiotic suscepti-
bility testing using the Paper Disc Method (Bio-Rad) on
Mueller-Hinton agar according to CLSI guidelines.
24,25
Phage typing. Vi-phage typing of the 90 Typhi isolates from
Son La province, 2002 and of the eight CS followed a stan-
dardized methodology as described previously.
8 Phage sus-
pensions were kindly provided by the Health Protection
Agency (Colindale, United Kingdom).
IS200 profiling. IS200 profiling using PstI (Roche, Mann-
heim, Germany) for the cleavage of the genomic DNA was
performed on 33 selected Typhi isolates from Son La prov-
ince, 2002, and on eight CS, as described previously.
26
Ribotyping. The membranes used for IS200 profiling were
reprobed with digoxigenin (DIG)-labeled OligoMix5 probe
as described previously.
26 Fifteen Typhi isolates, which exhib-
ited different representative ribotypes, were subjected to the
RiboPrinter microbial characterization system (Qualicon,
Wilmington, DE), a fully automated and standardized ri-
botyping method for creating a database. Ribotype number-
ing was generated by this system. Image normalization and
construction of similarity matrices were carried out using
BioNumerics 4.0 (Applied Maths, Sint-Martens-Latem, Bel-
gium). Ribotype profiles were compared with the RiboPrinter
database of the NRC-Salm (1997–2004, 339 PstI-ribotypes of
Typhi).
Pulsed-field gel electrophoresis. Pulsed-field gel electro-
phoresis (PFGE) of XbaI (Roche)-digested genomic DNA
was carried out on a subset of 29 Typhi from Son La, 2002,
and on eight CS, as described previously.
27 The running con-
ditions and the molecular size marker (XbaI-digested DNA
from S. enterica serotype Braenderup H9812) were the same
as described in the standardized PulseNet protocol.
28 Image
normalization and construction of similarity matrices were
carried out using BioNumerics 4.0. Bands were assigned
manually, and clustering was performed using the unweighted
pair-group method with arithmetic averages (UPGMA)
based on the Dice similarity index, utilizing an optimization
parameter of 0.5% and a 1% band-position tolerance. Each
profile that differed by one or more bands was assigned a
type.
Haplotyping by denaturing high-performance liquid chro-
matography (DHPLC) analysis. Fifty-two polymorphic cod-
ing gene fragments (Table 1) were amplified from 37 strains,
including a subset of 31 Typhi from Son La and 6 CS, as
described previously.
29 PCR products were amplified over 25
cycles in 25 L volumes, containing 15 ng of DNA from each
of 4 test strains plus a reference strain (CT18), polymerase
(1.25 units, Optimase, Transgenomic, Omaha, NE), as well as
specific primers (320 nM, Table 1) and dNTPs (0.2 mM).
Duplex obtained after the reannealing of denatured PCR
fragments were analyzed by DHPLC with a DNA-SepR Car-
tridge (WaveR Nucleic Acid Fragment Analysis System,
Transgenomic) at the temperatures indicated in Table 1. Ac-
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showing evidence of mutations were purified and sequenced
from both strands by Agowa (Berlin, Germany).
RESULTS
Origin and antimicrobial susceptibility of Typhi isolates. A
total of 90 Typhi isolates (49 from blood culture only, 8 from
both blood and stool culture, and 33 from stool culture only)
were recovered from 90 patients with confirmed TF among
the 617 patients who were admitted with a suspected TF in
Son La province hospitals during the time of the study.
22
None of the patients infected with Typhi reported any travel
outside the province during the incubation period. The iso-
lates were recovered from patients living in four different
areas: Thuan Chau district (N  28), Phu Yen district (N 
32), Quynh Nhai district (N  23), and Son La town (N  7).
Isolates from Thuan Chau district were recovered from pa-
tients living in two villages: Lai Le Phong Lai (N  9) and Lai
Cang Phong Lai (N  19) during an outbreak that occurred
during weeks 40 and 41 (September–October). Isolates from
Phu Yen district were recovered in patients from 11 commu-
nities of Yen Ha village during an outbreak that occurred in
week 46 in November (N  31) or afterward in December
TABLE 1
Polymorphic gene fragments tested by denaturing HPLC analysis on Typhi strains isolated from Son La province, Vietnam, 1995–2002
Gene
Fragment
length (bp)
DHPLC
temp (°C) 5–3 Forward/reverse primers
STY0006 483 60.7 CAGTTTCCGTTGTCGCAG/TCGTATCCCCCTCACCCT
STY0135 497 60.8 TACGTGACGTCCGATGTAGG/GGATAGACATGCTCGCTGC
STY0175 428 61.4 CACATCTCTCCGGGCATCTA/CCTGCAAAGATGCCTTCC
STY0214 482 63.2 TGGGACGTCATGAATGGC/CGCCTGAGTCACATTCAGAG
STY0321 440 64.0 GTTACTGCACCGCACACAGA/CAGGGAAGTGGTCTTCGTTG
STY0336 462 60.0 CCAGGGACTTATCGAGTGGA/GACACGCCACGCACCTATAT
STY0573 429 62.9 GATAACCCGTTGGTGGGG/ACCGTGACGATGGACCAC
STY0831 436 62.9 CCCGGCAACTATGAGCTG/GCCCTATGGTCTGAATCAGG
STY0961 434 61.4 CTGTATGGCACCGGTCAAC/GGAACCCAGACTTCGAGGT
STY0962 500 60.5 GACGCAAGAAGAGTGGATGC/CGATATGAACTTCGCCGC
STY1097 467 62.1 TACCCGTGAACACGTTCG/GGAACGTACGGGCAGTAATC
STY1121 435 59.6 CGCATTTGATCCTCGACC/ACTCACGCATAACGGGCA
STY1286 415 62.9 GAACTCCTGGCAGCTTGC/CACCGACTCTCACACCCAA
STY1327 411 62.4 CTCCAGAATTGGCTGTAGGG/GAGCTGCTGACCCGACTA
STY1556 432 61.9 GGTTTTCATCCCCGGAAC/GGGCGTAACTTCGTCACCTT
STY1693 430 60.7 CAGCTCAGGGTCCCCATA/AACTGCACCGTGTGCCTT
STY1720 411 59.3 CCTGCGGCCATATAAGCTAC/TCAGGAGGCAAGCAATGC
STY1808 435 61.2 GCATGGTCCTGACATTCCC/CGAGTATGGTTCGGCAGG
STY1919 436 63.4 ACAGTTCGGCCTACGAGGT/GCCACCTGAGGAATAGCG
STY1947 454 62.7 GACCGCCCACAGGTTTTC/GCCGGAACCTCTGATTGA
STY1948 418 61.0 CGACAACCTCGGGTTTGAC/CAACAAGGGCTGGGACTC
STY2093 416 61.3 GTTAACTCACCTGTCTGCCC/CCTCACGGCGGTACTAAGGT
STY2211 462 61.7 CTCGTAACCCTCCACAGTGC/AGACGGCAGACGGTCTGTT
STY2281 651 65 GTCGGTCTGTATATTCCCGG/GGTAATCGCATCCACCAAATC
STY2389 500 60.7 CGAGCCGAGTTTACACTGC/CGGGAGCAATTACGTGTG
STY2441 476 62.9 CGTATGTTCGCTGGACTCG/CAGACTGGGAACGCTTTG
STY2513 408 64.1 CCTGTCATGGCGAAGACAC/TTCACAGACCAGGCTACGGT
STY2575 439 61.5 ACAAGAGGAGAAGCTGCTCG/CAGCTCATCCGATACGCA
STY2621 458 64.1 GCGGCACATAGGTCGTCA/TGTGCTGGGTACGGGAAT
STY2629 435 55.6 GGAGAACTACTCCGTGGAGG/CGGGACTGGTCCAATGAA
STY2711 407 62.1 CCCGGAGATTGGCTATACG/CTTTTACGCTCTGGGCTTCC
STY2785 474 63.4 AGTACATGCAGGCCTGCC/GGGCATCGACTTAGGCACT
STY2834 479 61.3 GTTTCATCCCACTGCCCT/CGGACCAGCCGTACACTAAG
STY2877 434 62.3 AATGGCTAACCTGTGCGG/GCGTCAGGTTCTCTCGTAGG
STY2948 423 63.2 AGACGTCCGCCGTTAGATC/GCTCCACCGATTTGGGTA
STY2971 468 63.2 ATATTCGGCGTGCTCAGC/GTTCTACGTCCACCGTGGTA
STY3033 409 62.3 ATCGGCAGTTACGTTCCG/CATAGCTCTTACTTGCCGCG
STY3082 413 62.9 CGGAGTGCTGAGTCGGTT/CGGGGAAGTGTTCGTTACTG
STY3196 410 61.0 CCAGACCCCAGCTCTTCTC/GGACATGTACCTGCGTATCG
STY3444 413 61.0 ACGTCCCTTACCACAACTGC/GAAAGGCGTGTAAGCCCAC
STY3499 444 62.1 CAGGTTGAGCTAACGCCC/CGGGATAACGTACTCCGG
STY3507 448 60.0 CTGTTCGTAGGTCAGGGAGA/AGAGTCAAGGCAGCGACTG
STY3614 458 61.3 GATGGACTATCACGTTCCGG/GAGCCTCGCAATGTATAGCC
STY3622 567 63.8 GTGGCCTGGAGTTTTCCACT/GACCAATAGCCGACAGCGTAG
STY3876 418 62.1 GCGAGCGATTAGCCACTATC/CACGCGTAACAGACGAGTCT
STY3940 404 60.1 CGTGTATATGCACTCCGAGC/CGTTAGAGCGTAGACGCTTG
STY4417 431 61.8 CGAGTTCTGGGACTGGGTC/CGATAAAGTCACACGGCACC
STY4499 436 63.2 CGCGACCTACGATAATGG/AGCACCCACTATTACGACGC
STY4545 467 62.1 GTGACCGAACCCCAGTTCTA/TCGAGACGTAACGCTGAGGT
STY4562 499 58.5 CAACAGGCTCCGGAGTTGT/GTAACCGCTGGCTACTCCCT
STY4793 444 61.1 TGGATGCCACTCCTGACAC/GGCATGACCAACCCACAC
STY4851 404 58.3 AACATACCCCCAGCTCTCG/CATCCTAAGTGGCGTGACAG
WEILL AND OTHERS 1176(N  1). Isolates from Quynh Nhai district were recovered
from patients living in the village of Pac Ma during an out-
break that occurred in weeks 31–34 (July–August, N  19) or
afterward in weeks 38 and 39 (September, N  4). Isolates
from Son La town were sporadically recovered from patients
living in three villages—Nam Hua La (N  2), Ne Nua (N 
3), and Hia Hua La (N  2)—during weeks 36–40 (Septem-
ber–October).
Antimicrobial susceptibility testing revealed that 94.5%
(85/90) of the Typhi isolates collected in 2002 were fully sus-
ceptible to amoxicillin, chloramphenicol, trimethoprim, tetra-
cycline, and nalidixic acid (Table 2). Four isolates (4.4%)
displayed single resistance to amoxicillin. One isolate dis-
played single resistance to sulfamethoxazole (1.1%). When
compared with the data of 116 Typhi strains collected during
routine surveillance in Son La province from 1995 to 1999, the
results clearly indicate a decline in the occurrence of MDR
and MDR-Nal
R Typhi isolates collected in this province in
recent years (Table 2).
Molecular and phage typing of Typhi isolates. Vi-phage
typing was done for the 90 Typhi isolates from Son La prov-
ince, 2002. All but five (94.4%) were of phage type A. Four
isolates were degraded Vi-strain (DVS) and one was Vi-
negative (Table 2).
For the molecular typing study, 33 Typhi isolates from Son
La province were selected: 9 from Phu Yen (N  32), 10 from
Thuan Chau (N  28), 7 from Quynh Nhai (N  23), and 7
from Son La town (N  7). We used four molecular methods
to study the genotypic relationship among these isolates: PstI-
IS200 typing, PstI-ribotyping, XbaI-PFGE (only 29 isolates
were typed by PFGE), and the newly described haplotyping
by DHPLC.
To compare the Typhi genotypes circulating in Son La
province in 2002 to other genotypes previously observed in
northern provinces or currently observed in southern Viet-
nam, we have also tested seven CS recovered from 1995 to
2002 in different provinces of Vietnam and displaying various
antimicrobial-resistance phenotypes (Table 3).
Only two PstI-IS200 profiles were observed in our study:
profile IS1 was present in the 33 selected Typhi isolates from
Son La province, whereas profile IS2 was observed in the 8
CS (including reference strain Ty-2) (Table 3, Figure 1A).
Fifteen PstI-ribotypes were found: 10 (S007, 177, 340, 343-
349) in Son La province isolates and 5 (03a, 26a, 187, 236 and
73/34/8) in CS (Table 3, Figure 1B). Ribotype 344 was the
most frequently observed ribotype in Son La province isolates
(19/33, 57.6%), whereas it was not found in CS.
By using XbaI-PFGE, 14 distinct profiles were found: 9
(X1–X9) in Son La province isolates and 5 (X10–X14) in CS
(Table 3, Figure 2A). Profile X1 was the most frequently
observed PFGE profile in PFGE-typed Son La province iso-
lates (19/29, 65.5%), whereas it was not found in CS. Profile
X2 differed from X1 by an additional low-molecular-weight
band of ≈ 70 kb, possibly corresponding to a plasmid. Profiles
X3–X9 differed from X1 by one to four bands > 100 kb.
Clustering analysis performed by UPGMA revealed that
Typhi isolates from Son La province clustered together (85%
similarity) (Figure 2B). A significant genetic diversity was
observed between the Son La province isolates and the CS.
Combination of the three classic molecular typing methods
results indicated that IS1-344-X1 was the most frequently en-
countered combined profile in Son La province isolates (12/
29, 41.4%). This combined profile was observed in outbreak
or sporadic isolates collected from Son La town and from all
the three districts of the study (Table 3).
By using the newly described haplotyping method, only one
haplotype, H68 was obtained among the 31 isolates from Son
La (Table 3). This haplotype was characterized by two syn-
onymous single-nucleotide polymorphisms (sSNP) located in
the genes HemD and fadD and by an insertion of 17 nucle-
otides in the gene STY2629, compared with the haplotype of
reference CT18. Four additional haplotypes were found in the
CS, the haplotype of 162/95 and 119/96 were unique whereas
230/95, 14/96, 358/98, and 339/98 harbored the same haplo-
type, H58.
DISCUSSION
The present study revealed that almost all of the Typhi
isolates collected from four outbreaks and sporadic cases in
Son La province, Vietnam, in 2002 were susceptible to classic
first line antibiotics. It is an interesting finding because MDR
and MDR-Nal
R Typhi isolates have been established in this
province since at least 1995 and 1997, respectively. A decline
of MDR Typhi isolates has been noted in India, whereas, in
contrast to our study, isolates with a single resistance to na-
lidixic acid (and a decreased susceptibility to ciprofloxacin)
were reported to increase.
16,17,30 Throughout Vietnam, emer-
gence of Typhi isolates that are resistant only to nalidixic acid
has also been observed since 2002 (H. Le, unpublished data).
The discrepancy between the trends of antimicrobial resis-
tance in Son La province and other regions of Vietnam may
be explained by differences in geography and access to health
care. In Son La province, TF outbreaks were often restricted
to small communities living in mountainous areas. Because of
poor road quality (it can take 2 days to reach study sites from
Son La town) and a very low average income, access to an-
tibiotics is limited. In richer Vietnamese regions, antibiotics
can be bought over the counter and self-medication is com-
mon.
The genetic relatedness of the Typhi strains isolated in Son
La province in 2002 was assessed using phage typing and four
molecular typing methods. All but four isolates from Son La
in 2002 were of phage type A. The remaining isolates could
not be typed (DVS and Vi negative). In a previous study, E1
(N  38) and E3 (N  24) were the most frequent phage
types observed in 81 epidemiologically independent MDR
Typhi isolates collected throughout Vietnam during 1995–
TABLE 2
Antibiotic susceptibility of Typhi strains isolated from Son La prov-
ince, Vietnam, 1995–2002
Antibiotic
% Resistance
1995
(n  15)
1996
(n  27)
1997
(n  28)
1998
(n  33)
1999
(n  13)
2002
(n  90)
Amoxicillin 100 63.0 92.9 72.7 30.8 4.4
Ceftriaxone 0 0000 0
Tetracycline 100 66.7 92.9 63.6 30.8 0
Cotrimoxazole 93.3 63.0 92.9 72.7 30.8 0
Chloramphenicol 0 66.7 92.9 72.7 30.8 0
Nalidixic acid 0 0 3.6 27.3 7.7 0
Norfloxacin 0 0000 0
Ciprofloxacin ND ND ND ND ND 0
ND, not determined.
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8 In another study, untypeable Vi (UVS) and E1 were
the most frequent phage types found in four outbreaks caused
by MDR or MDR-Nal
R Typhi isolates in Vietnam during
1993–1997.
7
Haplotyping revealed that the strains isolated in Son La
bore a unique haplotype, H68, which was characterized by
combination of 2 sSNP located in the genes HemD and fadD
and a 17-bp insertion located in the gene STY2629 (Figure 3).
The HemD SNP was common among Vietnamese strains,
whereas the 17-bp insertion was Son La-specific. This inser-
tion was not present among 480 worldwide strains, including
149 susceptible MDR and MDR-Nal
R Typhi strains isolated
from several Vietnamese regions.
29 In addition, XbaI-PFGE,
considered the method of choice for subtyping Typhi, re-
vealed that the Son La isolates were highly related with pro-
files clustering into the same group with a similarity of
85%.
5,7,9,31–39 The ribotyping results were more difficult to
interpret. One ribotype, 344, was found in 57.6% of the iso-
lates. Seven isolates with a predominant PFGE profile, X1,
showed ribotypes other than 344. For these isolates, we could
have performed PFGE with another restriction enzyme to
check if these isolates belonged to the same or to different
clones. However, in studies involving Typhi, use of additional
enzymes did not significantly enhance the discriminatory
power of XbaI-PFGE alone.
35,36,39 Rather than suggesting
different clones, ribotyping results could be explained by pos-
sible homologous recombinations between rrn operons of re-
lated isolates, as previously described by Echeita and Usera.
40
As these rearrangements can dramatically modify the ri-
botype and subsequently disturb cluster analysis, ribotyping
TABLE 3
Characteristics of 33 selected Typhi isolates from Son La province, Vietnam, 2002, and of 8 Typhi comparison strains*
Isolate Date Origin
Sex/age
group†
Geographic origin
Antimicrobial
resistance pattern‡
Phage
type
IS200
type Ribo-type
PFGE
type Haplo-type Province District Village
Outbreak 1 (23 cases)
1 14/08 Blood F/IV Son La Quynh Nhai Pac Ma Susceptible A IS1 349 X9 H68
3 11/08 Blood F/III Son La Quynh Nhai Pac Ma Susceptible A IS1 343 X1 H68
7 10/08 Blood M/IV Son La Quynh Nhai Pac Ma Susceptible A IS1 344 X1 H68
9 10/08 Blood M/IV Son La Quynh Nhai Pac Ma Susceptible A IS1 S007 X1 H68
13 24/09 Blood M/IV Son La Quynh Nhai Pac Ma Susceptible A IS1 344 X1 H68
15 11/08 Blood M/IV Son La Quynh Nhai Pac Ma Susceptible A IS1 344 X1 H68
19 22/09 Stools M/IV Son La Quynh Nhai Pac Ma Susceptible A IS1 348 X6 H68
Sporadic cases (7 cases)
23 04/08 Blood F/IV Son La Son La town Nam A A IS1 S007 X5 H68
24 18/09 Stools F/IV Son La Son La town Nam Susceptible A IS1 344 X1 H68
25 20/09 Blood M/IV Son La Son La town Ne Nua Susceptible A IS1 344 X1 H68
26 08/09 Blood M/IV Son La Son La town Ne Nua A DVS IS1 345 X1 H68
27 09/09 Stools M/IV Son La Son La town Hia Susceptible A IS1 344 X9 H68
28 23/09 Blood F/IV Son La Son La town Hia Susceptible A IS1 340 X4 H68
30 10/09 Blood M/IV Son La Son La town Ne Nua Susceptible A IS1 344 ND H68
Outbreak 2 (28 cases)
31 01/10 Stools M/IV Son La Thuan Chau Lai Le Susceptible A IS1 344 ND H68
33 01/10 Stools F/IV Son La Thuan Chau Lai Le Susceptible A IS1 345 X1 H68
36 01/10 Stools F/IV Son La Thuan Chau Lai Le Susceptible A IS1 344 X1 H68
39 10/10 Blood F/IV Son La Thuan Chau Lai Le Susceptible DVS IS1 344 X1 H68
40 01/10 Stools M/IV Son La Thuan Chau Lai Cang A A IS1 344 X2 H68
41 01/10 Blood F/IV Son La Thuan Chau Lai Cang Susceptible A IS1 344 ND H68
46 01/10 Stools F/IV Son La Thuan Chau Lai Cang Sul A IS1 347 X1 H68
48 02/10 Blood F/IV Son La Thuan Chau Lai Cang Susceptible A IS1 344 X1 H68
52 04/10 Stools F/IV Son La Thuan Chau Lai Cang Susceptible A IS1 344 X1 H68
55 10/10 Stools F/IV Son La Thuan Chau Lai Cang Susceptible A IS1 346 X3 H68
Outbreak 3 (32 cases)
59 13/10 Blood M/IV Son La Phu Yen Yen Ha Susceptible A IS1 344 X1 H68
61 13/10 Stools M/IV Son La Phu Yen Yen Ha Susceptible A IS1 S007 X1 H68
65 13/10 Blood M/IV Son La Phu Yen Yen Ha Susceptible A IS1 344 X1 H68
68 13/10 Blood M/IV Son La Phu Yen Yen Ha Susceptible A IS1 177 X8 H68
72 13/10 Blood M/IV Son La Phu Yen Yen Ha Susceptible A IS1 177 X8 H68
74 13/10 Blood M/IV Son La Phu Yen Yen Ha Susceptible A IS1 344 X7 H68
78 13/10 Stools M/IV Son La Phu Yen Yen Ha Susceptible A IS1 S007 X1 H68
85 12/10 Stools M/IV Son La Phu Yen Yen Ha Susceptible A IS1 344 X1 H68
89 12/10 Stools M/IV Son La Phu Yen Yen Ha Susceptible A IS1 344 ND H68
Comparison strains
162/95 Sep 95 Ha Bac§ Susceptible A IS2 187 X12 H75
119/96 Jan 96 Ha Tay§ Susceptible M3 IS2 26a X13 H50
230/95 Oct 95 Than Hoa§ ACSulTpTe E1 IS2 236 X10 H58
14/96 Jan 96 Son La ACSulTpTe E1 IS2 236 X10 H58
339/98 1998 Ha Tay ACSulTpTeNal E1 IS2 03a X11 H58
358/98 Jan 98 Than Hoa ACSulTpTeNal E1 IS2 03a X11 H58
CM2664 Jun 02 HCMC§ ACSulTpTeNal E1 IS2 03a X11 ND
Ty-2 Reference strain ND ND IS2 73/34/8 X14 H10
* Abbreviations: ND, not determined; DVS, degraded Vi strain.
† Age group I, < 1 year; II, 1–5 years; III, 6–14 years; IV, 15–64 years; V, > 65 years.
‡ Antimicrobial resistance patterns: A, amoxicillin; C, chloramphenicol; Sul, sulfonamides, Tp, trimethoprim; Te, tetracycline; Nal, nalidixic acid.
§ Ha Bac, Ha Tay, and Than Hoa are northern provinces of Vietnam. HCM, Ho Chin Minh City (HCMC) is in southern Vietnam.
WEILL AND OTHERS 1178should be used with caution and concomitantly with other
methods like PFGE during epidemiologic investigations.
It remains difficult to define whether the Son La clone had
emerged from a local strain or had been imported. Only a
single earlier isolate from Son La province was available for
the present study (other isolates were not stored). This MDR-
Nal
R isolate (14/96) collected in 1996 was characterized by a
different haplotype, IS200-type, and phage type in compari-
son with the 2002 clone. This 14/96 isolate was similar to
230/95, an MDR isolate collected in 1995 in Than Hoa prov-
ince, located near Son La province. They both belong to the
H58 haplotype, which is now found predominantly in Viet-
nam and South Asia in MDR and MDR-Nal
R Typhi strains.
29
This suggests that the Son La susceptible clone did not
emerge from a plasmid-purged MDR Typhi strain.
In the absence of earlier isolates collected in Son La prov-
ince, we have no information on when exactly the clone
emerged in this province. Molecular analysis performed in the
past showed that, in contrast to MDR, susceptible Typhi
strains displayed extensive genetic heterogeneity.
35,41 The
very weak genetic diversity of the Son La clone suggests that
it might have emerged rather recently in Son La province.
FIGURE 2. A, Representative XbaI-PFGE profiles obtained from the 29 typed Typhi isolates and the 8 comparison strains under study. M, S.
enterica serotype Braenderup H9812 used as the molecular size marker (band sizes in kilobase pairs). PFGE profile numbering is indicated. B,
Dendrogram generated by BioNumerics showing the results of cluster analysis on the basis of PFGE fingerprinting. Similarity analysis was
performed using the Dice coefficient, and clustering was by UPGMA. Numbers in parentheses refer to the number of isolates with the indicated
PFGE profile.
FIGURE 1. Representative IS200 profiles A, and PstI-ribotypes B, obtained from the 33 selected Typhi isolates and the 8 comparison strains
under study. A, Lanes 1–9, IS1 type; lane 10, IS2 type. B, Image generated by BioNumerics. M, Riboprinter marker size (band sizes in kilobase
pairs). Ribotype numbering according to BBPE-Unit database is indicated. Asterisks indicate the ribotypes observed in isolates from Son La
province, 2002.
ANTIBIOTIC-SUSCEPTIBLE SALMONELLA TYPHI, SON LA PROVINCE, VIETNAM 1179This susceptible clone could have been established in Son La
province as early as 1997, when MDR isolates were reported
to decrease, or as late as 2002. It could have been acquired
before circulation of MDR or MDR-Nal
R Typhi isolates and
maintained in chronic carrier(s) until favorable epidemiologic
conditions associated with the disappearance of antibiotic se-
lective pressure, leading to its dissemination in Son La prov-
ince. In the first hypothesis, the circulation of this clone dur-
ing the last decade might have resulted in a network of car-
riers harboring the same or a closely derived strain and being
the source of small independent outbreaks in distinct com-
munities. In the second hypothesis, the three outbreaks and
the sporadic cases of 2002 were related. The previous epide-
miologic study did not support this hypothesis. However, the
possibility of a village-to-village dissemination during the 10-
week period by healthy carriers was not investigated (only TF
cases were investigated). Healthy carriers could have con-
taminated people through point source contaminated food or
more probably through water from wells or streams. Drinking
untreated water and poor hygiene habits were among the risk
factors found to be associated with TF in the province (83/90
cases and 149/180 controls).
22 Nevertheless, in the absence of
earlier isolates, the cause(s) that should explain the Son La
province scale replacement of the MDR/MDR-Nal
R Typhi
strains by a single susceptible clone described herein re-
main(s) unclear. The Son La paradox sheds light on the pos-
sible shift from multiresistant populations to a susceptible
population in one region where TF is already endemic. Un-
derstanding the epidemiologic situation that has led to this
shift of populations in Son La would be very important for TF
control.
The finding that four amoxicillin-resistant isolates have
been detected among isolates belonging to the emerging or
re-emerging clone(s) indicates that acquisition of resistance
determinants is already started. Reasons for emergence of
resistance are well documented and are most probably pre-
ventable. A resurgence of MDR and MDR-Nal
R Typhi iso-
lates in Son La province, whatever their clonal lineage, should
be prevented by the use of classic first-line antibiotics adapted
to the results of the monitoring of antimicrobial susceptibility
when feasible. Education of health professionals to ensure
appropriate antibiotic prescriptions and education of patients
to avoid self-medication should be emphasized.
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